HPC differentiation

"HPC differentiation" describes the biological process by which hematopoietic progenitor cells (HPCs)—multipotent cells produced in the course of hematopoiesis—undergo lineage specification and maturation to yield various blood cell types, including erythroid, myeloid, and lymphoid lineages. This process is regulated by transcription factors, epigenetic changes, cell surface markers (such as CD34, CD43), and signaling pathways including mTOR, Wnt, and Notch, and is influenced by the bone marrow microenvironment and extracellular factors. Rather than being a canonical therapeutic target or molecule, "HPC differentiation" is a complex cellular program studied in the contexts of development, regenerative medicine, disease modeling, and cell therapy. Monitoring HPC differentiation is essential in clinical and research settings for assessing the effectiveness of engraftment, lineage potential, and for the diagnosis and prognosis of hematological diseases.

Other names

Hematopoietic progenitor cell differentiationDifferentiation of HPCsHematopoietic stem and progenitor cell differentiation